Use Delcath Systems Inc. management performance together with your portfolio to protect against small markets fluctuations and to determine Stock optimization strategy that fits your criteria.
Delcath Management Effectiveness
The company has return on total asset (ROA) of (96.49) % which means that it has lost $96.49 on every $1 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (193.35) % meaning that it created substantial loss on money invested by shareholders.
Delcath Systems Inc. is rated below average in number of employees category among related companies. The total workforce of Drug Delivery industry is currently estimated at about 23,621. Delcath adds roughly 80.0 in number of employees claiming only tiny portion of equities under Drug Delivery industry.
Mr. Eamonn P. Hobbs is President, Chief Executive Officer, Director of Decalth Systems Inc., since October 2008. He was appointed President and Chief Executive Officer of Delcath in July 2009 and was a director of Delcat...
Mr. Harold S. Koplewicz, M.D., is Independent Chairman of the Board of Decalth Systems Inc., since February 1, 2007. He was a Director of the company since September 2006. He is one of the nation?s child and adolescent p...
Delcath employes about 80 people. The company is managed by 20 executives with total tenure of roughly 43 years, averanging almost 2.0 years of service per executive having 4.0 employee per reported executive.
Return on Delcath Manpower
Net Loss Per Employee
549.1 K
Net Loss Per Executive
2.2 M
Working Capital Per Employee
169.7 K
Working Capital Per Executive
678.7 K
Delcath Earnings Per Share
According to company disclosure Delcath Systems Inc. has Earnings Per Share of -0.94 times. This is 188.68% lower than that of Healthcare sector, and 280.77% lower than that of Drug Delivery industry, The Earnings Per Share for all stocks is 162.67% higher than the company.
Earnings per Share is one of the most important measures of current share price of a firm, and is used by investors to determine company overall profitability especially when it is compared to EPS of similar companies.